| Q38346848 | A GT-rich sequence binding the transcription factor Sp1 is crucial for high expression of the human type VII collagen gene (COL7A1) in fibroblasts and keratinocytes |
| Q51504143 | A case of dystrophic epidermolysis bullosa: surgical treatment for hand contracture using abdominal skin flap. |
| Q28270168 | A missense mutation in type VII collagen in two affected siblings with recessive dystrophic epidermolysis bullosa |
| Q36382518 | A recombinant tail-less integrin beta 4 subunit disrupts hemidesmosomes, but does not suppress alpha 6 beta 4-mediated cell adhesion to laminins. |
| Q37082009 | Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells |
| Q30650123 | Aminoglycosides restore full-length type VII collagen by overcoming premature termination codons: therapeutic implications for dystrophic epidermolysis bullosa. |
| Q41452411 | Basement-membrane stromal relationships: interactions between collagen fibrils and the lamina densa |
| Q36438308 | Basic fibroblast growth factor: a missing link between collagen VII, increased collagenase, and squamous cell carcinoma in recessive dystrophic epidermolysis bullosa |
| Q58058165 | Chapter 8 Extracellular matrix |
| Q24315966 | Cloning of the human type XVII collagen gene (COL17A1), and detection of novel mutations in generalized atrophic benign epidermolysis bullosa |
| Q52526907 | Collagen VII expression in human chronic wounds and scars. |
| Q40853815 | Collagens and their abnormalities in a wide spectrum of diseases |
| Q24675846 | Compound heterozygosity for a dominant glycine substitution and a recessive internal duplication mutation in the type XVII collagen gene results in junctional epidermolysis bullosa and abnormal dentition |
| Q71708643 | Cytokine gene expression in epidermis with biological effects following injection of naked DNA |
| Q40878358 | Development and characterization of a recombinant truncated type VII collagen "minigene". Implication for gene therapy of dystrophic epidermolysis bullosa |
| Q40872692 | Dohi memorial lecture. Clinical implications of basic research on heritable skin diseases |
| Q24312098 | Dominant dystrophic epidermolysis bullosa: identification of a Gly-->Ser substitution in the triple-helical domain of type VII collagen |
| Q34140802 | Elevated expression of type VII collagen in the skin of patients with systemic sclerosis. Regulation by transforming growth factor-beta |
| Q40392062 | Epidermolysis Bullosa: Pathogenetic Pathways from Mutations to Symptoms |
| Q24678450 | Epidermolysis bullosa with pyloric atresia: novel mutations in the beta4 integrin gene (ITGB4) |
| Q41633647 | Epidermolysis bullosa: a spectrum of clinical phenotypes explained by molecular heterogeneity |
| Q40399909 | Epidermolysis bullosa: hereditary skin fragility diseases as paradigms in cell biology |
| Q35824190 | Epidermolytic hyperkeratosis (bullous congenital ichthyosiform erythroderma). Genetic linkage to chromosome 12q in the region of the type II keratin gene cluster |
| Q33904940 | Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa |
| Q90602418 | Expression of Laminin 332 in Vesicant Skin Injury and Wound Repair |
| Q35023324 | Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs). |
| Q34128047 | Herlitz junctional epidermolysis bullosa keratinocytes display heterogeneous defects of nicein/kalinin gene expression |
| Q28298121 | Identification of a leucine-to-proline mutation in the keratin 5 gene in a family with the generalized Köbner type of epidermolysis bullosa simplex |
| Q52676772 | Identification of novel enriched recurrent chimeric COL7A1-UCN2 in human laryngeal cancer samples using deep sequencing. |
| Q39178646 | In vitro analysis of photosensitizer accumulation for assessment of applicability of fluorescence diagnosis of squamous cell carcinoma of epidermolysis bullosa patients |
| Q33712943 | Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa |
| Q45876048 | Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa |
| Q42487637 | Interferon-gamma-mediated inactivation of transcription of the 230-kDa bullous pemphigoid antigen gene (BPAG1) provides novel insight into keratinocyte differentiation |
| Q45877035 | Intradermal injection of lentiviral vectors corrects regenerated human dystrophic epidermolysis bullosa skin tissue in vivo |
| Q40704596 | Intravenously Administered Recombinant Human Type VII Collagen Derived from Chinese Hamster Ovary Cells Reverses the Disease Phenotype in Recessive Dystrophic Epidermolysis Bullosa Mice. |
| Q34071975 | Laminins and human disease |
| Q40705517 | Low-dose methotrexate treatment in elderly patients with bullous pemphigoid |
| Q40511466 | Molecular basis for the dystrophic forms of epidermolysis bullosa: mutations in the type VII collagen gene |
| Q24309362 | Molecular basis of dystrophic epidermolysis bullosa: mutations in the type VII collagen gene (COL7A1) |
| Q34412417 | Molecular complexity of the cutaneous basement membrane zone |
| Q34319775 | Murine muscular dystrophy caused by a mutation in the laminin alpha 2 (Lama2) gene |
| Q54557716 | Mutation analyses of COL7A1 gene in three Taiwanese patients with severe recessive dystrophic epidermolysis bullosa. |
| Q33657782 | Mutation analysis and molecular genetics of epidermolysis bullosa |
| Q24308020 | Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa |
| Q28243912 | Mutations in the gamma 2 chain gene (LAMC2) of kalinin/laminin 5 in the junctional forms of epidermolysis bullosa |
| Q40789915 | Non-infectious diseases of the oral soft tissue: a new approach |
| Q36610899 | Novel molecular therapies for heritable skin disorders |
| Q24562156 | Premature termination codons on both alleles of the type VII collagen gene (COL7A1) in three brothers with recessive dystrophic epidermolysis bullosa |
| Q36437677 | Prenatal diagnosis for recessive dystrophic epidermolysis bullosa in 10 families by mutation and haplotype analysis in the type VII collagen gene (COL7A1) |
| Q35910642 | Progress in epidermolysis bullosa: genetic classification and clinical implications |
| Q37499984 | Progress in heritable skin diseases: translational implications of mutation analysis and prospects of molecular therapies*. |
| Q35855573 | The cartilage matrix protein subdomain of type VII collagen is pathogenic for epidermolysis bullosa acquisita. |
| Q34355367 | The genetics of human skin disease |
| Q41948258 | The intracellular functions of alpha6beta4 integrin are regulated by EGF. |
| Q73109070 | The role of immunohistochemistry in the diagnosis of the non-lethal forms of junctional epidermolysis bullosa |
| Q58068797 | The tylosis esophageal cancer (Toc) locus: more than just a familial cancer gene* |
| Q42484455 | Tissue-specific expression of the 230-kDa bullous pemphigoid antigen gene (BPAG1). Identification of a novel keratinocyte regulatory cis-element KRE3. |
| Q41815771 | Topical application of recombinant type VII collagen incorporates into the dermal-epidermal junction and promotes wound closure |
| Q30427003 | Zebrafish: a model system to study heritable skin diseases |